Narcotic Solutions Launches “Made in Germany” Logistics Services for Narcotics and Medical Cannabis

New Joint Venture by LOXXESS and MSK Goes Live

• Under the umbrella of Narcotic Solutions, the two German family-owned companies LOXXESS pharma & healthcare and MSK Pharma Group jointly offer “Made in Germany” logistics services for narcotics (BtM) and medical cannabis (MedCan).
• With a combined portfolio of more than 100 pharmaceutical clients, the partners bring extensive experience in advising and supporting pharmaceutical companies.

Meerbusch, October 1, 2026. LOXXESS pharma & healthcare and MSK Pharma Group have established a joint venture: Narcotic Solutions provides end-to-end logistics services for narcotics (BtM) and medical cannabis (MedCan) in the German market. Any company wishing to distribute narcotics or medical cannabis in Germany must utilize a national warehouse and distribution infrastructure that meets the highest standards of security, documentation, and quality.

To meet these requirements, both partners have combined their strengths within the specialized joint venture Narcotic Solutions. The venture offers dedicated infrastructure, in-depth operational expertise in narcotics and medical cannabis logistics, and comprehensive regulatory know-how. Clients benefit from access to the extensive and experienced quality teams of both family-owned companies.

“Medical cannabis, narcotics, and highly regulated pharmaceuticals require the highest standards of patient safety, regulatory compliance, and resilient supply chains. As family-owned businesses, both partners stand for sustainable entrepreneurship. The strong commitment of our shareholders enables us to implement this cooperation reliably for our clients, invest purposefully in security and compliance, and develop the business on a sound economic basis,” says Robert Mauermann, Member of the Executive Board of the LOXXESS Group.

A Dedicated Logistics Site

A state-of-the-art, dedicated facility in Meerbusch, North Rhine-Westphalia, has been established for the storage and distribution of narcotics and medical cannabis, meeting the highest security standards. The site combines specialized security infrastructure with pharmaceutical process expertise, including narcotics handling authorization, wholesale distribution authorization, GDP and GMP expertise, serialization, quality control services, and support for customer-specific quality management systems.

“We are planning sustainable and organic growth for our logistics offering of narcotics and medical cannabis distribution from Germany to Europe. Together, we provide specialized narcotics expertise combined with the full capabilities of two experienced, family-owned pharmaceutical and healthcare logistics providers,” says Simon Heß, CEO of MSK Pharma Group.

Especially in the field of narcotics and medical cannabis, the challenge extends far beyond secure storage. Regulatory requirements, licenses, documentation obligations, and changing market conditions frequently raise complex questions for pharmaceutical companies. LOXXESS and MSK address these challenges through their joint offering. It is more than a logistics solution; it helps ensure the continuous availability of critical medicines.

About MSK Pharma Group

For nearly 30 years, MSK Pharma Group has been a family-owned pharmaceutical services provider specializing in temperature-controlled pharmaceutical logistics, GMP-compliant packaging, and quality management. Clients from the pharmaceutical and medical technology industries benefit from tailored logistics, packaging, and kitting solutions for highly regulated environments.

As a pharmaceutical specialist, MSK not only provides warehousing and distribution services but also offers added-value services in serialization, QA/QP services, wholesale distribution, and market entry support for Germany and Europe. Through its “Company-as-a-Service” model, MSK can even provide a complete market presence for international pharmaceutical companies.

Its clients include manufacturers of generics, orphan drugs, biosimilars, OTC products, and medical devices.

Headquartered in Heppenheim, MSK Pharma Group employs approximately 250 people, operates its logistics center in Bensheim, and manages 40,000 square meters of temperature-controlled and certified warehouse space. The company is certified according to GMP, GDP, ISO 9001, and ISO 13485, and holds manufacturing, import, and wholesale distribution licenses pursuant to Sections 13, 73a, and 52a of the German Medicines Act (AMG).

Further information: www.msk-pharmalogistic.de

About LOXXESS

The LOXXESS Group is a Europe-wide contract logistics provider specializing in pharmaceutical logistics, e-commerce, and customized logistics solutions. Its clients from industry and retail benefit from tailored logistics and fulfillment services designed for complex and individual requirements.

As a logistics specialist, LOXXESS supports its clients not only in procurement and distribution but also through value-added services in customer service, product customization, accounts receivable management, and e-business.

The company’s client base ranges from start-ups and medium-sized enterprises to international corporations.

Headquartered in Tegernsee, LOXXESS employs more than 3,200 people, operates 24 locations across Germany, the Czech Republic, and Poland, and manages 380,000 square meters of warehouse space. The company has received multiple awards for innovative logistics solutions, including the European Logistics Award from the European Logistics Association (ELA).

Further information: www.loxxess.com